Robbins Farley’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.19M | Sell |
27,954
-391
| -1% | -$30.6K | 1.02% | 39 |
|
|
2025
Q1 | $2.05M | Sell |
28,345
-17
| -0.1% | -$1.23K | 1.09% | 41 |
|
|
2024
Q4 | $2.1M | Buy |
28,362
+258
| +0.9% | +$19.1K | 1% | 41 |
|
|
2024
Q3 | $1.85M | Buy |
28,104
+8,335
| +42% | +$550K | 0.93% | 46 |
|
|
2024
Q2 | $1.83M | Buy |
19,769
+1,110
| +6% | +$103K | 0.97% | 43 |
|
|
2024
Q1 | $1.78M | Sell |
18,659
-995
| -5% | -$95.1K | 0.94% | 44 |
|
|
2023
Q4 | $1.5M | Buy |
19,654
+5,436
| +38% | +$414K | 0.9% | 48 |
|
|
2023
Q3 | $985K | Buy |
14,218
+941
| +7% | +$65.2K | 0.67% | 51 |
|
|
2023
Q2 | $1.25M | Buy |
13,277
+5,029
| +61% | +$474K | 0.87% | 46 |
|
|
2023
Q1 | $682K | Buy |
8,248
+179
| +2% | +$14.8K | 0.46% | 50 |
|
|
2022
Q4 | $602K | Sell |
8,069
-14,238
| -64% | -$1.06M | 0.47% | 46 |
|
|
2022
Q3 | $1.84M | Sell |
22,307
-301
| -1% | -$24.9K | 1.51% | 30 |
|
|
2022
Q2 | $2.15M | Sell |
22,608
-1,809
| -7% | -$172K | 2.24% | 21 |
|
|
2022
Q1 | $2.87M | Buy |
+24,417
| New | +$2.87M | 2.16% | 19 |
|
|
2021
Q4 | – | Sell |
-24,250
| Closed | -$2.75M | – | 175 |
|
|
2021
Q3 | $2.75M | Buy |
+24,250
| New | +$2.75M | 2.02% | 21 |
|
|
2021
Q2 | – | Sell |
-26,423
| Closed | -$2.39M | – | 117 |
|
|
2021
Q1 | $2.39M | Buy |
26,423
+107
| +0.4% | +$9.67K | 2.1% | 27 |
|
|
2020
Q4 | $2.4M | Buy |
+26,316
| New | +$2.4M | 2.36% | 18 |
|